Registered Nurse in Darrington, WA Accepting Medicare
3 Registered Nurse nurses found. Showing 1 - 3
 Barbara Jean Cheyney, R.N. Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 1075 Fir Street, Darrington, WA 98241 Phone: 360-436-1313 |
Jean M Wessel, ARNP Registered Nurse - Case Management Medicare: Not Enrolled in Medicare Practice Location: 5318 Chief Brown Ln, Darrington, WA 98241 Phone: 360-436-2210 Fax: 360-436-2226 |
Ms. Kathy A. Slate, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 1075 Fir Street, Darrington, WA 98241 Phone: 360-436-1313 Fax: 360-436-0592 |
News Archive
Appointment of former British MP to head IRC will affect autonomy of humanitarian agencies
The appointment of David Miliband - who on Wednesday resigned his seat as Member of Parliament for South Shields - as president and CEO of the International Rescue Committee (IRC) "is another nail in the coffin to claims of humanitarian independence," Michiel Hofman, senior humanitarian specialist for the Humanitarian Innovation Team of Médecins Sans Frontières (MSF), writes in The Guardian's "Comment is Free" blog.
Potent monoclonal antibody shows promise against emerging SARS-CoV-2 variants of concern
In a new study currently available on the bioRxiv* preprint server, a group of US-based researchers developed a panel of neutralizing monoclonal antibodies against SARS-CoV-2 that can block viral attachment to cells – and pinpointed a specific one that can potently neutralize all tested variants of concern.
New 4th Edition of Practical Neurology for clinicians, residents and fellows
The new 4th Edition of Practical Neurology, the respected "real-life" guide to diagnosing and managing neurologic disorders, has been completely rewritten to known neurologist and chair of the Department of Neurology of Loyola University Chicago Stritch School of Medicine.
New cancer drug enters phase I clinical trials in humans
A new drug that prompts cancer cells to self-destruct while sparing healthy cells is now entering phase I clinical trials in humans. The drug, called PAC-1, first showed promise in the treatment of pet dogs with spontaneously occurring cancers, and is still in clinical trials in dogs with osteosarcoma.
The efficacy and safety of Rituximab in patients with active rheumatoid arthritis
Drugs aimed at suppressing inflammation-provoking cytokines-specifically those linked to T-cells-have improved the treatment of rheumatoid arthritis (RA), a chronic, inflammatory autoimmune disease. Still, the frequency of remission achieved by these biologic agents remains below 50 percent.
› Verified 7 days ago